Literature DB >> 10699601

Clinical states in prostate cancer: toward a dynamic model of disease progression.

H I Scher1, G Heller.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10699601     DOI： 10.1016/s0090-4295(99)00471-9

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


× No keyword cloud information.
  61 in total

Review 1.  Targeting osseous metastases: rationale and development of radio-immunotherapy for prostate cancer.

Authors:  Michael J Morris; Neeta Pandit-Taskar; Chaitanya Divgi; Steven Larson; Howard I Scher
Journal:  Curr Oncol Rep       Date:  2004-05       Impact factor: 5.075

Review 2.  Targeting the androgen receptor in prostate and breast cancer: several new agents in development.

Authors:  Tracy Proverbs-Singh; Jarett L Feldman; Michael J Morris; Karen A Autio; Tiffany A Traina
Journal:  Endocr Relat Cancer       Date:  2015-02-26       Impact factor: 5.678

3.  (11)C-acetate PET imaging in prostate cancer.

Authors:  Michael J Morris; Howard I Scher
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-02       Impact factor: 9.236

Review 4.  Anatomic and Molecular Imaging in Prostate Cancer.

Authors:  Eric T Miller; Amirali Salmasi; Robert E Reiter
Journal:  Cold Spring Harb Perspect Med       Date:  2018-03-01       Impact factor: 6.915

Review 5.  Integrins in prostate cancer progression.

Authors:  Hira Lal Goel; Jing Li; Sophia Kogan; Lucia R Languino
Journal:  Endocr Relat Cancer       Date:  2008-06-04       Impact factor: 5.678

6.  Cost-effectiveness of fracture prevention in men who receive androgen deprivation therapy for localized prostate cancer.

Authors:  Kouta Ito; Elena B Elkin; Monica Girotra; Michael J Morris
Journal:  Ann Intern Med       Date:  2010-05-18       Impact factor: 25.391

7.  SIRT1 enhances matrix metalloproteinase-2 expression and tumor cell invasion in prostate cancer cells.

Authors:  Jenna D Lovaas; Lijia Zhu; Christine Y Chiao; Vanessa Byles; Douglas V Faller; Yan Dai
Journal:  Prostate       Date:  2012-10-04       Impact factor: 4.104

Review 8.  Novel tracers and their development for the imaging of metastatic prostate cancer.

Authors:  Andrea B Apolo; Neeta Pandit-Taskar; Michael J Morris
Journal:  J Nucl Med       Date:  2008-11-07       Impact factor: 10.057

9.  Phase II trial of docetaxel with rapid androgen cycling for progressive noncastrate prostate cancer.

Authors:  Dana Rathkopf; Michael A Carducci; Michael J Morris; Susan F Slovin; Mario A Eisenberger; Roberto Pili; Samuel R Denmeade; Moshe Kelsen; Tracy Curley; Melinda Halter; Connie Collins; Martin Fleisher; Glenn Heller; Sharyn D Baker; Howard I Scher
Journal:  J Clin Oncol       Date:  2008-06-20       Impact factor: 44.544

10.  Integrin signaling aberrations in prostate cancer.

Authors:  Hira Lal Goel; Naved Alam; Isaac N S Johnson; Lucia R Languino
Journal:  Am J Transl Res       Date:  2009-04-20       Impact factor: 4.060
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.